黄素对心脏脂毒性的有益影响
Sajad Abolfazli1, Alexandra E Butler2, Prashant Kesharwani3
1Student Research Committee, School of Pharmacy, Mazandaran University Medical Science, Sari, Iran.
The Journal of pharmacy and pharmacology
|August 24, 2024
概括
来自黄的黄素通过减少心脏细胞中的脂肪积累来对抗心脏脂毒性. 它通过抑制细胞死亡和炎症来缓解肥胖和糖尿病引起的心脏功能障碍.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂毒性,或子宫外脂质在心脏等器官中的积累,损害心脏功能,并与肥胖和糖尿病有关.
- 这种情况源于一种代谢转变,有利于脂肪酸氧化而不是葡萄糖氧化,导致有毒脂质的积累.
- 脂毒性压力的关键分子参与者包括脂肪酸,二甲,胺,以及像MAPK和PPAR这样的信号通路.
研究的目的:
- 调查黄素对心脏脂毒性的保护作用.
- 阐明黄素减轻心肌细胞中脂毒压力的分子机制.
主要方法:
- 这项研究侧重于库尔库的已知药理特性,库尔库是一种从Curcuma longa.提取的多.
- 分析黄素对参与脂毒性细胞过程的影响,包括细胞亡,炎症和内质网膜应激.
主要成果:
- 黄素通过抑制亡和减少相关蛋白质的表达来表现出心脏保护作用.
- 它降低了促炎性细胞因子和内分泌网膜压力标志物的表达.
- 黄激活了自信号通路,有助于清除有毒脂质.
结论:
- 黄素有效降低心脏脂毒性,为脂毒性心肌病提供了潜在的治疗策略.
- 它的机制包括抑制亡,炎症和内质网膜压力,同时促进自.
- 黄素的多方面的药理作用凸显了它在治疗影响心脏的代谢障碍方面的潜力.
更多相关视频
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.1K
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
126
相关概念视频
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...